Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
525.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (0.765%)
Market Cap: £302.10m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Trading Update

28 Jan 2020 07:00

RNS Number : 0771B
Mortgage Advice Bureau(Holdings)PLC
28 January 2020
 

28 January 2020

Mortgage Advice Bureau (Holdings) plc 

("MAB" or the "Group")

Trading Update 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1), one of the UK's leading consumer intermediary brands and specialist Appointed Representative networks, today issues a trading update for the year ended 31 December 2019, ahead of publishing its final results on Tuesday, 24 March 2020(1).

Revenue for the year increased by 16% to £143m, with strong organic revenue growth of 10% (11% on an underlying basis(2)) to £135m for the core MAB business driven by a 14% increase in the average number of core MAB Advisers for the year to 1,293 (2018: 1,130). First Mortgage Direct Limited ("First Mortgage"), which was acquired on 2 July 2019, contributed an additional £8m of revenue.

We increased the total number of Advisers at the year end by 20% to 1,457 (2018:1,213), with organic growth in adviser numbers of 13% or 162 to 1,375, supplemented by the 82 Advisers brought into the Group with First Mortgage. 

Activity in the housing market was impacted by the continuing political and economic uncertainties associated with Brexit, particularly in the earlier part of 2019, and we saw a drop in underlying average annual revenue per Adviser for the core MAB business of 3%. However, we have seen improving productivity through H2 2019, relative to H1 2019, and we expect the UK General Election result along with the many focused initiatives that MAB has in place, including process efficiencies and lead generation, supported by our technology developments, to generate growth in revenue per Adviser in 2020, irrespective of the level of activity in the broader market. 

UK Finance(3) estimates that gross new mortgage lending for 2019 was £266bn, a 1% reduction on 2018. The Intermediary Mortgage Lenders Association's current estimates (published post the general election) are £268bn for gross new mortgage lending in 2020 and £275bn in 2021.

The Group's profit before tax for the year ended 31 December 2019 is in line with the Board's expectations. At 31 December 2019, the Group had a strong balance sheet with a cash position of £21m, including £7m of unrestricted cash balances. At the year end the Group had no borrowings drawn down on its revolving credit facility (which was put in place at the time of the First Mortgage acquisition), demonstrating the strong cash generation of MAB's business model.

(1) It is expected that a proposed final dividend in respect of the year ended 31 December 2019 will be paid on 29 May 2020 to shareholders on the register at close of business on 1 May 2020.

(2) Underlying basis excludes a one-off adjustment in H1 2018 of £1.7m for procuration fees awaiting processing

(3) UK Finance estimates for gross new mortgage lending for 2020 and 2021 were published before the general election in December 2019

Peter Brodnicki, CEO of MAB, said:

"MAB has delivered another strong performance despite the prolonged political and economic uncertainties throughout 2019. We continue to deliver on our strategy to grow our market share in all conditions by investing to ensure sustainable growth whilst maintaining a strong financial position. 

"We are capitalising upon our protection and lead generation initiatives to further improve performance and continue to pilot our new technology platform, with rollout to a number of our ARs in the first half of 2020. These initiatives are important recruitment drivers for ARs, Advisers and lead sources."

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Enquiries:

Mortgage Advice Bureau (Holdings) plc +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Lucy Tilley, Chief Financial Officer

Nominated Adviser and Broker: +44 (0)20 7260 1000

Numis Securities Limited

Stephen Westgate / Hugo Rubinstein (Corporate Finance)

Michael Burke (Corporate Broking)

 

Media Enquiries:

 

investorrelations@mab.org.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEWEFWESSEFF
Date   Source Headline
1st Dec 20255:25 pmRNSDirectors' Shareholdings and PDMR notification
18th Nov 20252:11 pmRNSDirectors' Shareholdings and PDMR notification
14th Nov 20257:00 amRNSNotice of Capital Markets Day Update
7th Nov 20255:15 pmRNSHolding(s) in Company
4th Nov 20251:34 pmRNSDirector/PDMR Shareholding
16th Oct 202512:40 pmRNSDirector/PDMR Shareholding
16th Oct 202512:38 pmRNSGrant of Options, PDMR Dealing,Total Voting Rights
30th Sep 20254:43 pmRNSDirector/PDMR Shareholding
25th Sep 20254:30 pmRNSDirector/PDMR Shareholding
23rd Sep 20255:01 pmRNSBlock listing Interim Review
23rd Sep 20257:00 amRNSInterim Results
17th Sep 20252:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20257:00 amRNS-RNotice of HY25 Results and Investor Presentation
29th Aug 20251:13 pmRNSDirector/PDMR Shareholding
27th Aug 20254:26 pmRNSHolding(s) in Company
21st Aug 20253:01 pmRNSDirector/PDMR Shareholding
31st Jul 202511:32 amRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSTrading Update
22nd Jul 20255:59 pmRNSEBT Share Purchase
17th Jul 20259:46 amRNSDirector/PDMR Shareholding
16th Jul 20251:58 pmRNSHolding(s) in Company
9th Jul 20259:05 amRNS-RMAB Launches First-Time Buyer Campaign
3rd Jul 20259:54 amRNSDirector/PDMR Shareholding
27th Jun 20253:46 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSBoard Changes
18th Jun 202510:55 amRNSDirector/PDMR Shareholding
11th Jun 202510:18 amRNSHolding(s) in Company
3rd Jun 20252:47 pmRNSDirector/PDMR Shareholding
30th May 20253:52 pmRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSResults of Annual General Meeting
21st May 20257:00 amRNSAGM Trading Statement
16th May 202512:30 pmRNSDirector/PDMR Shareholding
6th May 202512:37 pmRNSHolding(s) in Company
1st May 20255:19 pmRNSDirectors' Shareholdings and PDMR notification
30th Apr 20255:15 pmRNSGrant of Options, PDMR Dealing and TVR
29th Apr 20258:48 amRNSNotice of AGM
17th Apr 20251:40 pmRNSHolding(s) in Company
16th Apr 20259:58 amRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSAppointment of Joint Corporate Broker
4th Apr 20257:10 amRNSAnnual Report and Notice of AGM
1st Apr 20253:51 pmRNSDirector/PDMR Shareholding
27th Mar 20259:18 amRNSHolding(s) in Company
19th Mar 20257:00 amRNSDirectorate Change
18th Mar 20257:00 amRNSFinal Results for the year ended 31 December 2024
17th Mar 20253:40 pmRNSDirector/PDMR Shareholding
14th Mar 20257:00 amRNSBlock Admission Application
5th Mar 202511:29 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNS-RNotice of Investor Presentation
18th Feb 20253:57 pmRNSDirector/PDMR Shareholding
17th Feb 20253:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.